intraoperative neuromonitoring market

Intraoperative Neuromonitoring Market by Source Type (Insourced Monitoring and Outsourced Monitoring), Product & Service (System, Accessory, and Service), Application (Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, Orthopedic Surgery, and Other Surgeries), Modality (Motor Evoked Potential [MEP], Somatosensory Evoked Potential [SSEP], Electroencephalography [EEG], Electromyography [EMG], Brainstem Auditory Evoked Potential [BAEP], and Visual Evoked Potential [VEP]), and End User (Hospital and Ambulatory Surgical Center): U.S. Opportunity Analysis and Industry Forecast, 2014 - 2022

  • Published Date: 2020-10-18
  • Report ID: 3240
  • Pages: 245
  • Format: prudent report format

U.S. Intraoperative Neuromonitoring Market Overview :

The U.S. intraoperative neuromonitoring (IONM) market generated $1,239 million in 2015 and is projected to reach $1,938 million by 2022, growing at a CAGR of 6.6% from 2016 to 2022. Intraoperative neurophysiological monitoring (IONM) or intraoperative neuromonitoring is a technique to reduce the risk of neurological deficits after surgical procedures that involve the nervous system. IONM utilizes recordings of electrical potentials from the nervous system during surgical procedures. Neuromonitoring is useful because it offers an opportunity to detect injuries before they become severe. Therefore, with the introduction of IONM, the risk of debilitating deficits, such as muscle weakness, paralysis, hearing loss, and other loss of normal body functions, is reduced.

The U.S. IONM market is expected to grow at a significant rate during the forecast period, owing to growth in the aging population, increase in prevalence of chronic disorders, surge in applications of IONM in different surgeries, and rise in risk management through IONM during complex surgeries. Furthermore, stringent regulations for IONM procedures and easy availability of technologically advanced IONM systems & accessories fuel the market growth.

The U.S. IONM market is studied based on product & service, source type, application, modality, end user, and state. Based on product & service, the market is segmented into system, accessory, and service. On the basis of source type, the market is bifurcated into insourced monitoring and outsourced monitoring. As per end user, the market is categorized into hospital and ambulatory surgical center (ASC). IONM finds its application in spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries related to the central or peripheral nervous system. IONM modalities include motor evoked potential (MEP), somatosensory evoked potential (SSEP), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potential (BAEP), and visual evoked potential (VEP). State-wise, the market is analyzed across California, Texas, New York, Florida, Illinois, Colorado, Louisiana, Michigan, Oklahoma, Alaska, Massachusetts, Delaware, Vermont, Connecticut, North Dakota, New Hampshire, Rhode Island, Maine, West Virginia, Pennsylvania, South Dakota, Minnesota, New Jersey, Ohio, Wisconsin, Maryland, Nebraska, Wyoming, Indiana, Montana, Iowa, Missouri, Oregon, Kentucky, Washington, Kansas, Mississippi, Virginia, Arkansas, Tennessee, South Carolina, Hawaii, Alabama, North Carolina, New Mexico, Idaho, Nevada, Georgia, Arizona, and Utah.

Key Benefits for U.S. Intraoperative Neuromonitoring Market :

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all states of the U.S. is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the U.S. market.

U.S. Intraoperative Neuromonitoring Key Market Segments :

By Product & Service

System

Accessory

Service

By Source Type

Insourced monitoring

Outsourced monitoring

By Application

Spinal surgery

Neurosurgery

Vascular surgery

ENT surgery

Orthopedic surgery

Other surgery

By Modality

Motor evoked potential (MEP)

Somatosensory evoked potential (SSEP)

Electroencephalography (EEG)

Electromyography (EMG)

Brainstem auditory evoked potential (BAEP)

Visual evoked potential (VEP)

By End User

Hospital

Ambulatory surgery center

By State

California

Texas

New York

Florida

Illinois

Colorado

Louisiana

Michigan

Oklahoma

Alaska

Massachusetts

Delaware

Vermont

Connecticut

North Dakota

New Hampshire

Rhode Island

Maine

West Virginia

Pennsylvania

South Dakota

Minnesota

New Jersey

Ohio

Wisconsin

Maryland

Nebraska

Wyoming

Indiana

Montana

Iowa

Missouri

Oregon

Kentucky

Washington

Kansas

Mississippi

Virginia

Arkansas

Tennessee

South Carolina

Hawaii

Alabama

North Carolina

New Mexico

Idaho

Nevada

Georgia

Arizona

Utah

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Accurate Monitoring, LLC.

Computational Diagnostics, Inc.

Intranerve, LLC.

Inomed Medizintechnik GmbH

Medtronic Plc

Moberg Research, Inc. (DAYONE MEDICAL, LLC.)

Natus Medical Incorporated

Nihon Kohden Corporation

Nuvasive, Inc.

Specialtycare

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Medsurant Health

Abea Neurodiagnostics, Inc.

Real Time Neuromonitoring Associates


Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top player positioning, 2015

3.3. IONM procedures in the U.S., by year
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in prevalence of chronic disorders
3.4.1.2. Surge in U.S. geriatric population
3.4.1.3. Risk management through IONM during complex surgeries

3.4.2. Restraint

3.4.2.1. Additional expenses associated with the insourced monitoring

3.4.3. Opportunity

3.4.3.1. Increase in application of IONM in different surgeries

3.4.4. Impact Analyses

Chapter: 4: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Insourced monitoring

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Outsourced monitoring

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

Chapter: 5: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCT & SERVICES

5.1. Overview

5.1.1. Market size and forecast

5.2. System

5.2.1. Market size and forecast

5.3. Accessory

5.3.1. Market size and forecast

5.4. IONM service

5.4.1. Market size and forecast

Chapter: 6: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY

6.1. Overview

6.1.1. Market size and forecast

6.2. Motor evoked potentials (MEPs)

6.2.1. Market size and forecast

6.3. Somatosensory evoked potentials (SSEPs)

6.3.1. Market size and forecast

6.4. Electroencephalography (EEG)

6.4.1. Market size and forecast

6.5. Electromyography (EMG)

6.5.1. Market size and forecast

6.6. Brainstem auditory evoked potentials (BAEPs)

6.6.1. Market size and forecast

6.7. Visual evoked potentials (VEPs)

6.7.1. Market size and forecast

Chapter: 7: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION

7.1. Overview

7.1.1. Market size and forecast

7.2. Spinal surgery

7.2.1. Market size and forecast

7.3. Neurosurgery

7.3.1. Market size and forecast

7.4. Orthopedic surgery

7.4.1. Market size and forecast

7.5. ENT surgery

7.5.1. Market size and forecast

7.6. Vascular surgery

7.6.1. Market size and forecast

7.7. Other surgeries

7.7.1. Market size and forecast

Chapter: 8: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER

8.1. Overview

8.1.1. Market size and forecast

8.2. Hospital

8.2.1. Market size and forecast

8.3. Ambulatory surgery Center

8.3.1. Market size and forecast

Chapter: 9: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY STATE

9.1. Overview

9.1.1. Market size and forecast

9.2. California

9.2.1. California IONM market, by application
9.2.2. California IONM accessory market

9.3. Texas

9.3.1. Texas IONM market, by application
9.3.2. Texas IONM accessory market

9.4. New York

9.4.1. New York IONM market, by application
9.4.2. New York IONM accessory market

9.5. Florida

9.5.1. Florida IONM market, by application
9.5.2. Florida IONM accessory market

9.6. Illinois

9.6.1. Illinois IONM market, by application
9.6.2. Illinois IONM accessory market

9.7. Colorado

9.7.1. Colorado IONM market, by application
9.7.2. Colorado IONM accessory market

9.8. Louisiana

9.8.1. Louisiana IONM market, by application
9.8.2. Louisiana IONM accessory market

9.9. Michigan

9.9.1. Michigan IONM market, by application
9.9.2. Michigan IONM accessory market

9.10. Oklahoma

9.10.1. Oklahoma IONM market, by application
9.10.2. Oklahoma IONM accessory market

9.11. Alaska

9.11.1. Alaska IONM market, by application
9.11.2. Alaska IONM accessory market

9.12. Massachusetts

9.12.1. Massachusetts IONM market, by application
9.12.2. Massachusetts IONM accessory market

9.13. Delaware

9.13.1. Delaware IONM market, by application
9.13.2. Delaware IONM accessory market

9.14. Vermont

9.14.1. Vermont IONM market, by application
9.14.2. Vermont IONM accessory market

9.15. Connecticut

9.15.1. Connecticut IONM market, by application
9.15.2. Connecticut IONM accessory market

9.16. North Dakota

9.16.1. North Dakota IONM market, by application
9.16.2. North Dakota IONM accessory market

9.17. New Hampshire

9.17.1. New Hampshire IONM market, by application
9.17.2. New Hampshire IONM accessory market

9.18. Rhode Island

9.18.1. Rhode Island IONM market, by application
9.18.2. Rhode Island IONM accessory market

9.19. Maine

9.19.1. Maine IONM market, by application
9.19.2. Maine IONM accessory market

9.20. West Virginia

9.20.1. West Virginia IONM market, by application
9.20.2. West Virginia IONM accessory market

9.21. Pennsylvania

9.21.1. Pennsylvania IONM market, by application
9.21.2. Pennsylvania IONM accessory market

9.22. South Dakota

9.22.1. South Dakota IONM market, by application
9.22.2. South Dakota IONM accessory market

9.23. Minnesota

9.23.1. Minnesota IONM market, by application
9.23.2. Minnesota IONM accessory market

9.24. New Jersey

9.24.1. New Jersey IONM market, by application
9.24.2. New Jersey IONM accessory market

9.25. Ohio

9.25.1. Ohio IONM market, by application
9.25.2. Ohio IONM accessory market

9.26. Wisconsin

9.26.1. Wisconsin IONM market, by application
9.26.2. Wisconsin IONM accessory market

9.27. Maryland

9.27.1. Maryland IONM market, by application
9.27.2. Maryland IONM accessory market

9.28. Nebraska

9.28.1. Nebraska IONM market, by application
9.28.2. Nebraska IONM accessory market

9.29. Wyoming

9.29.1. Wyoming IONM market, by application
9.29.2. Wyoming IONM accessory market

9.30. Indiana

9.30.1. Indiana IONM market, by application
9.30.2. Indiana IONM accessory market

9.31. Montana

9.31.1. Montana IONM market, by application
9.31.2. Montana IONM accessory market

9.32. Iowa

9.32.1. Iowa IONM market, by application
9.32.2. Iowa IONM accessory market

9.33. Missouri

9.33.1. Missouri IONM market, by application
9.33.2. Missouri IONM accessory market

9.34. Oregon

9.34.1. Oregon IONM market, by application
9.34.2. Oregon IONM accessory market

9.35. Kentucky

9.35.1. Kentucky IONM market, by application
9.35.2. Kentucky IONM accessory market

9.36. Washington

9.36.1. Washington IONM market, by application
9.36.2. Washington IONM accessory market

9.37. Kansas

9.37.1. Kansas IONM market, by application
9.37.2. Kansas IONM accessory market

9.38. Mississippi

9.38.1. Mississippi IONM market, by application
9.38.2. Mississippi IONM accessory market

9.39. Virginia

9.39.1. Virginia IONM market, by application
9.39.2. Virginia IONM accessory market

9.40. Arkansas

9.40.1. Arkansas IONM market, by application
9.40.2. Arkansas IONM accessory market

9.41. Tennessee

9.41.1. Tennessee IONM market, by application
9.41.2. Tennessee IONM accessory market

9.42. South Carolina

9.42.1. South Carolina IONM market, by application
9.42.2. South Carolina IONM accessory market

9.43. Hawaii

9.43.1. Hawaii IONM market, by application
9.43.2. Hawaii IONM accessory market

9.44. Alabama

9.44.1. Alabama IONM market, by application
9.44.2. Alabama IONM accessory market

9.45. North Carolina

9.45.1. North Carolina IONM market, by application
9.45.2. North Carolina IONM accessory market

9.46. New Mexico

9.46.1. New Mexico IONM market, by application
9.46.2. New Mexico IONM accessory market

9.47. Idaho

9.47.1. Idaho IONM market, by application
9.47.2. Idaho IONM accessory market

9.48. Nevada

9.48.1. Nevada IONM market, by application
9.48.2. Nevada IONM accessory market

9.49. Georgia

9.49.1. Georgia IONM market, by application
9.49.2. Georgia IONM accessory market

9.50. Arizona

9.50.1. Arizona IONM market, by application
9.50.2. Arizona IONM accessory market

9.51. Utah

9.51.1. Utah IONM market, by application
9.51.2. Utah IONM accessory market

Chapter: 10: COMPANY PROFILES

10.1. Accurate Monitoring LLC

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio

10.2. Computational Diagnostics, Inc.

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Product portfolio

10.3. IntraNerve, LLC

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio

10.4. inomed Medizintechnik GmbH

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.4.5. Key strategic moves and developments

10.5. Medtronic plc.

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.5.5. Business performance

10.6. Morberg Research, Inc. (Dayone Medical, LLC.)

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product portfolio

10.7. Natus Medical Incorporated

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.7.6. Key strategic moves and developments

10.8. Nihon Kohden Corporation

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Product portfolio
10.8.5. Business performance
10.8.6. Key strategic moves and developments

10.9. NuVasive, Inc.

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Key strategic moves and developments

10.10. SpecialtyCare

10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5.Key strategic moves and developments
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.